Aggravation of psoriasis by antimalarials: A comment on the pathogenic mechanism

Indian Journal of Dermatology, Venereology and Leprology

Volumn 74, Issue 6, 2008, Pages 675-676

  Namazi, M ^a,b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIMALARIAL AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; GEMFIBROZIL; HYDROXYCHLOROQUINE; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LITHIUM; MEVINOLIN; PROTEIN GLUTAMINE GAMMA GLUTAMYLTRANSFERASE; SQUALENE MONOOXYGENASE; TERBINAFINE;

CELL PROLIFERATION; CHOLESTEROL BLOOD LEVEL; CHOLESTEROL SYNTHESIS; CONCENTRATION RESPONSE; DISEASE EXACERBATION; DNA SYNTHESIS; DRUG BIOAVAILABILITY; DRUG MECHANISM; ENZYME ACTIVITY; EPIDERMIS; EPIDERMIS HYPERPLASIA; ERYTHEMA; IMMUNOMODULATION; INCUBATION TIME; KERATINOCYTE; LETTER; LYMPHOCYTE; PATHOGENESIS; PSORIASIS;

ANTIMALARIALS; CHOLESTEROL; HUMANS; PSORIASIS;

EID: 59149085088     PISSN: 03786323     EISSN: None     Source Type: Journal    
DOI: 10.4103/0378-6323.45131     Document Type: Letter

References (8)

1. Wolf R, Ruocco V. Triggered psoriasis. Adv Exp Med Biol 1999;455:221-5.
2. Wolf R, Schiavo AL, Lombardi ML, de Angelis F, Ruocco V. The in vitro effect of hydroxychloroquine on skin morphology in psoriasis. Int J Dermatol 1999;38:154-7.
3. FeingoldK R, Mac-QiangM, PredschE, MenonG K, BrownB E, EliasP M. The lovastatin-treated rodent: A new model of barrier disruption and epidermal hyperplasia. J Invest Dermatol 1991;96:201-9.
4. Namazi MR. Statins: Novel additions to the dermatologic arsenal? Exp Dermatol 2004;13:337-9.
5. Szepietowski JC. Terbinafine exacerbates psoriasis: Case report with a literature review. Acta Dermatovenerol Croat 2003;11:17-21.
6. Ardoin SP, Sandborg C, Schanberg LE. Management of dyslipidemia in children and adolescents with systemic lupus erythematosus. Lupus 2007;16:618-26.
7. Wo?niacka A, Lesiak A, Smigielski J, Sysa-Jedrzejowska A. Chloroquine influence on lipid metabolism and selected laboratory parameters. Przegl Lek 2005;62:855-9.
8. Beynen AC, van der Molen AJ, Geelen MJ. Inhibition of hepatic cholesterol biosynthesis by chloroquine. Lipids 1981;16:472-4.